Fingerprint
Dive into the research topics of 'Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically